Ouangré Abdourahmane, Yerbanga Isidore W, Savadogo Ibrahim, Ouédraogo Hamado, Bado Nebon Delphine, Nagalo André, Traoré Fagnima, Dem Abdoul Kader, Bouda Sibiri Abdoul Karim, Koulybari Djima Fahriane Dora, Sawadogo Abdoulaye, Nakanabo Diallo Seydou, Gangneux Jean-Pierre, Fahal Ahmed Hassan, Bamba Sanata
Service de traumatologie du CHU Régional de Ouahigouya, Ouahigouya, 01 BP 36 Ouahigouya 01, Burkina Faso.
Unité de Formation et de Recherche en Sciences de la Santé, Université Lédéa Bernard Ouédraogo, Ouahigouya 01 BP 346 Ouahigouya 01, Burkina Faso.
Trans R Soc Trop Med Hyg. 2025 Jun 5;119(6):570-577. doi: 10.1093/trstmh/traf015.
Mycetoma is a chronic inflammatory disease characterized by progressive and devastating granulomatous subcutaneous tissue involvement. It primarily occurs in regions classified within the 'mycetoma belt', encompassing various countries. Notably, West African nations, including Burkina Faso (BF), are situated within this belt, yet there is a significant lack of data regarding mycetoma in these regions. With this background, this study set out to determine the mycetoma prevalence in BF. A comprehensive review was conducted to document the presence of mycetoma in BF. Searches were performed in PubMed, ScienceDirect, African Journals Online (AJOL) and Google Scholar databases. Data were reported following the Preferred Reporting Items for Systematic and Meta-analyses (PRISMA) guidelines. Additionally, the study encompassed a case series involving three patients. From 1960 to 2024, 25 mycetoma cases have been documented in BF. Overall, the clinical cases share similar sociodemographic, clinical, diagnostic, therapeutic and outcome characteristics. Specifically, these cases illustrate that mycetoma predominantly affects vulnerable groups in BF. The majority of mycetoma cases (96%) were reported in the Sahelian zone of BF. Predominantly, these cases (80%) had foot mycetoma. This study highlights the challenges of mycetoma management in BF, indicating significant obstacles in early diagnosis and effective treatment.
足菌肿是一种慢性炎症性疾病,其特征是进行性且破坏性地累及皮下组织形成肉芽肿。它主要发生在被归类为“足菌肿带”的地区,涵盖多个国家。值得注意的是,包括布基纳法索(BF)在内的西非国家位于这个地带,但这些地区关于足菌肿的数据严重匮乏。在此背景下,本研究旨在确定布基纳法索的足菌肿患病率。进行了全面的综述以记录布基纳法索足菌肿的存在情况。在PubMed、ScienceDirect、非洲期刊在线(AJOL)和谷歌学术数据库中进行了检索。数据按照系统评价和Meta分析的首选报告项目(PRISMA)指南进行报告。此外,该研究包括一个涉及三名患者的病例系列。从1960年到2024年,布基纳法索已记录了25例足菌肿病例。总体而言,这些临床病例在社会人口统计学、临床、诊断、治疗和结局特征方面具有相似性。具体而言,这些病例表明足菌肿在布基纳法索主要影响弱势群体。大多数足菌肿病例(96%)报告于布基纳法索的萨赫勒地区。主要是这些病例(80%)患有足部足菌肿。本研究突出了布基纳法索足菌肿管理的挑战,表明在早期诊断和有效治疗方面存在重大障碍。